These studies add to existing knowledge by showing that NF-κB activation can underlie both COPD-like lung remodeling and lung cancer and by demonstrating the oncogenic potential of persistent NF-κB-generated inflammation. This evidence concerns the gene NFKB1 and lung carcinoma.